| Cardiotoxicity of Targeted Therapy for HER-2 Positive Breast Cancer Patients at High Altitude (NCT05063643) | Affiliated Hospital of Qinghai University | 2021-10-01 |
| Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment. (NCT06277388) | Sun Yat-sen University | 2021-06-05 |
| Radiation-induced Cardiac Toxicity After Non-small Cell Lung Cancer Radiotherapy (NCT04867564) | Military Institute od Medicine National Research Institute | 2021-05-01 |
| Risk Assessment Model of Trastuzumab-related Cardiotoxicity in Breast Cancer Patients (NCT04962425) | Peking University Third Hospital | 2021-01-08 |
| Exercise Response After Revalidation in Cancer Patients (NCT04461392) | Universitair Ziekenhuis Brussel | 2020-08-01 |
| Effects of Anti-VEGF Targeted Drugs on Patients' Blood Pressure and Endothelial Function (NCT04962438) | Peking University Third Hospital | 2019-07-05 |
| Association Between Telomere Length and Cardiac Dysfunction (NCT04409379) | Air Force Military Medical University, China | 2019-01-01 |
| The CAROLE (CArdiac Related Oncologic Late Effects) Study (NCT03235427) | Northwell Health | 2017-06-27 |
| BreAst Cancer and Cardiotoxicity Induced by RAdioTherapy: the BACCARAT Study (NCT02605512) | Sophie JACOB | 2015-10-01 |
| COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA) (NCT05258448) | Odense University Hospital | 2015-08-01 |
| Race Difference Moxifloxacin-induced QT Prolongation Between Healthy Chinese and Caucasian Volunteers (NCT02119091) | Haiyan Li | 2014-04-01 |
| MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum (NCT01719562) | Wake Forest University Health Sciences | 2013-01-01 |
| Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT) (NCT01032278) | M.D. Anderson Cancer Center | 2011-01-25 |
| Early Detection of Anthracycline Cardiotoxicity by Echocardiographic Analysis of Myocardial Deformation in 2D Strain (NCT01212926) | University Hospital, Bordeaux | 2010-09-28 |
| Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer (NCT01093235) | Cambridge University Hospitals NHS Foundation Trust | 2009-04-01 |
| Aerobic Exercise in Patients Receiving Chemotherapy for Cancer (NCT00728429) | Wake Forest University Health Sciences | 2008-06-01 |
| Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab (NCT00875238) | Vanderbilt University | 2008-06-01 |
| CADY Study ICORG 08-01 (NCT00968682) | Cancer Trials Ireland | 2008-04-01 |
| Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin (NCT00577798) | University of Nebraska | 2008-01-01 |
| Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery (NCT00436566) | Mayo Clinic | 2007-03-16 |
| Novel Surrogate Markers as Predictors of Radiation Toxicity in Breast Cancer Patients Undergoing Helical Tomotherapy Compared to Standard Radiation Therapy (NCT00563407) | AHS Cancer Control Alberta | 2006-07-01 |
| Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors (NCT00039481) | National Cancer Institute (NCI) | 2002-11-01 |
| Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer (NCT00016276) | National Cancer Institute (NCI) | 2001-05-01 |
| Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer (NCT00003070) | Children's Oncology Group | 2000-09-01 |
| Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma (NCT00003937) | Children's Oncology Group | 1999-09-01 |
| Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease (NCT00005578) | Children's Oncology Group | 1997-03-01 |
| SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial (NCT00002900) | SWOG Cancer Research Network | 1997-02-01 |
| Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease (NCT00002827) | Children's Oncology Group | 1996-10-01 |
| Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma (NCT01230983) | Children's Oncology Group | 1996-06-01 |